View News

Strides Shasun completes US FDA inspection at Bangalore plant

Strides Shasun completes US FDA inspection at Bangalore plant

Strides Shasun announces successful completion of US FDA inspection.

Strides Shasun announces successful completion of US FDA inspection at its Oral Dosage Facility in Bangalore.

The Bangalore facility manufactures oral dosage forms including tablets, capsules, ointments and liquids.
 

Strides Shasun Ltd ended at Rs. 1128.55, up by Rs. 9.9 or 0.88% from its previous closing of Rs. 1118.65 on the BSE.

The scrip opened at Rs. 1125 and touched a high and low of Rs. 1135 and Rs. 1118.2 respectively. A total of 362947(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 10085.4 crore.

The BSE group 'A' stock of face value Rs. 10 touched a 52 week high of Rs. 1412.45 on 23-Nov-2015 and a 52 week low of Rs. 848 on 29-Feb-2016. Last one week high and low of the scrip stood at Rs. 1135 and Rs. 1014.65 respectively.

The promoters holding in the company stood at 31.14 % while Institutions and Non-Institutions held 46.98 % and 21.88 % respectively.

The stock traded above its 200 DMA.

Add Comment

Cancel reply

Your email address will not be published. Required fields are marked *